Zanubrutinib/Sonrotoclax
泽布替尼/索托克拉
Report date: 2025/08/27 20:01:50
NME
Base Information
Drug NameZanubrutinib/Sonrotoclax
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes ZanubrutinibSonrotoclax
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBeOne Medicines Ltd
China Registration ClassN/A
Develop Information
Active CompaniesBeOne Medicines Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A